Cargando…

Galectin-3 as a Potential Biomarker of Microvascular Complications in Patients with Type 2 Diabetes

INTRODUCTION: Human Galectin-3 is a 32- to 35-kDa size lectin, mainly comprises a C-terminal carbohydrate recognition binding domain (CRD) and N-terminal domain. It acts as a powerful pro-inflammatory signalling factor, which plays an important role in the activation, chemotaxis, and cytokine releas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Surendra, Ranawat, Chandrapal S., Bhandiwad, Chandrashekhar, Arya, Harish, Mali, Manoj, Singh, Chandreshwar P., Sharma, Nitin, Lathwal, Navneet, Wasim, Sayad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815198/ https://www.ncbi.nlm.nih.gov/pubmed/36618522 http://dx.doi.org/10.4103/ijem.ijem_270_22

Ejemplares similares

Coronary Microvascular Dysfunction: Linking Inflammation and Cardiac Dysfunction?
por: Schindler, Thomas H., et al.
Publicado: (2023)

Association of low educational status with microvascular complications in type 2 diabetes: Jaipur diabetes registry
por: Sharma, Niharikaa, et al.
Publicado: (2015)

A Study of Rhino-Orbito-Cerebral Mucormycosis with COVID-19: A New Challenge in North West of Rajasthan
por: Kumar, Surendra, et al.
Publicado: (2022)

Galectins as Cancer Biomarkers
por: Balan, Vitaly, et al.
Publicado: (2010)

Association of low educational status with microvascular complications in type 2 diabetes: Jaipur diabetes registry-1
por: Sharma, Niharikaa, et al.
Publicado: (2015)

Vitamin D levels and microvascular complications in type 2 diabetes
por: Bajaj, Sarita, et al.
Publicado: (2014)

PET-determined prevalence of coronary microvascular dysfunction and different types in a cardio-metabolic risk population
por: Bhandiwad, Anita R., et al.
Publicado: (2023)

Retinal Vascular Caliber as a Biomarker for Diabetes Microvascular Complications
por: Ikram, M. Kamran, et al.
Publicado: (2013)

Diabetic Microvascular Complications
por: Migdalis, I., et al.
Publicado: (2018)

SAT205 (99)Technitiumm Sestamibi Negative Sporadic Metastatic Parathyroid Carcinoma In A Young Female-A Diagnostic Conundrum
por: Sheker Reddy, Danda Vijay, et al.
Publicado: (2023)

Gene Expression Dynamics in Rice Peduncles at the Heading Stage
por: Kandpal, Manu, et al.
Publicado: (2020)

Diabetic Microvascular Complications: Novel Risk Factors, Biomarkers, and Risk Prediction Models
por: McKay, Gareth J., et al.
Publicado: (2016)

Galectin-1 and Galectin-9 Concentration in Maternal Serum: Implications in Pregnancies Complicated with Preterm Prelabor Rupture of Membranes
por: Boroń, Dorota Grażyna, et al.
Publicado: (2022)

Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways
por: Zakir, Mehreen, et al.
Publicado: (2023)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chauhan, Anubhav, et al.
Publicado: (2016)

Anatomical model broncho-trainer: A new training device
por: Verma, Anil Kumar, et al.
Publicado: (2014)

Anatomical model broncho-trainer: A new training device: Corrigendum
por: Sharma, Manoj Kumar, et al.
Publicado: (2014)

The Correlation of the Neutrophil-to-Lymphocyte Ratio With Microvascular Complications in Patients With Diabetes Mellitus
por: Mahajan, Mayank, et al.
Publicado: (2023)

Evaluation of Chitotriosidase and Neopterin as Biomarkers of Microvascular Complications in Patients with Type 1 Diabetes Mellitus
por: Cutaș, Ancuța, et al.
Publicado: (2021)

Determinants and Stratification of Microvascular Complications of Type 2 Diabetes Mellitus
por: Reddy Mallimala, Priya, et al.
Publicado: (2023)

Galectin-3 as a prognostic biomarker for diabetic nephropathy
por: Hodeib, Hossam, et al.
Publicado: (2019)

Serum galectins as potential biomarkers of inflammatory bowel diseases
por: Yu, Tony B., et al.
Publicado: (2020)

Galectin-1 as a predictive biomarker in ovarian cancer
por: Masoodi, Mahak, et al.
Publicado: (2021)

Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?
por: Soccio, Raymond E
Publicado: (2021)

Galectin-10 as a Potential Biomarker for Eosinophilic Diseases
por: Tomizawa, Hiroki, et al.
Publicado: (2022)

Galectin-1 and -3 in high amounts inhibit angiogenic properties of human retinal microvascular endothelial cells in vitro
por: Hillenmayer, Anna, et al.
Publicado: (2022)

Inflammation and diabetic retinal microvascular complications
por: Zhang, Wenbo, et al.
Publicado: (2011)

Inflammation in the pathogenesis of microvascular complications in diabetes
por: Nguyen, Dung V., et al.
Publicado: (2012)

MicroRNA and Microvascular Complications of Diabetes
por: Barutta, F., et al.
Publicado: (2018)

The Role of Biofactors in Diabetic Microvascular Complications
por: Ziegler, Dan, et al.
Publicado: (2022)

Genetics of diabetes-associated microvascular complications
por: Lyssenko, Valeriya, et al.
Publicado: (2023)

P-019: ENDOTHELIAL ACTIVATION BIOMARKERS FOR THE RISK OF CHRONIC MICROVASCULAR COMPLICATIONS IN SICKLE CELL DISEASE
por: I., AGOUTI, et al.
Publicado: (2022)

Galectin-10, a Potential Biomarker of Eosinophilic Airway Inflammation
por: Chua, Justin C., et al.
Publicado: (2012)

Galectin-3: a novel biomarker for the prognosis of heart failure
por: AMIN, HILMAN ZULKIFLI, et al.
Publicado: (2017)

Efficacy evaluation of serum galectin-3 in hypertension complicated with diastolic dysfunction
por: Dong, Tianwei, et al.
Publicado: (2020)

Emerging roles of Galectin-3 in diabetes and diabetes complications: A snapshot
por: Li, Yanhua, et al.
Publicado: (2022)

Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR)
por: Hutter, Stefan, et al.
Publicado: (2016)

Cardiac computed tomography-derived extracellular volume fraction in the identification of cardiotoxicity: Another emerging imaging option
por: Schindler, Thomas H., et al.
Publicado: (2021)

The Development and Future of Reconstructive and Microvascular Surgery of the Hand
por: Malahias, Marco, et al.
Publicado: (2014)

Circulating Biomarkers in Coronary Microvascular Dysfunction
por: Chakrala, Teja, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lfuappu537s5dmi6r8ulto1u2r